≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Disease of thymus, other/unspecified

DOID Endpoint Browser PheWeb

E4_THYMUSDISNAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E32.8, E32.9
  • Hospital discharge: ICD-9 — 254[8-9]
  • Hospital discharge: ICD-8 — 25499
  • Cause of death: ICD-10 — E32.8, E32.9
  • Cause of death: ICD-9 — 254[8-9]
  • Cause of death: ICD-8 — 25499

2 out of 7 registries used, show all original rules.

61

4. Check minimum number of events

None

61

5. Include endpoints

None

61

6. Filter based on genotype QC (FinnGen only)

61

Control definitions (FinnGen only)

Control exclude
E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 334 201 131
Only index persons 276 163 113
Unadjusted period prevalence (%)
Whole population 0.00 0.01 0.00
Only index persons 0.01 0.01 0.00
Median age at first event (years)
Whole population 54.02 57.68 48.43
Only index persons 49.25 52.02 45.26

-FinnGen-

Key figures

All Female Male
Number of individuals 61 40 21
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 48.36 48.16 48.74

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
52
Matched controls
522
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E32.9
ICD-10 Finland
Disease of thymus, unspecified
+∞
44.2
36
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
10.8
11.4
24
38
25499
ICD-8 Finland
Diseases of thymus gland
+∞
9.7
9
*
E32.8
ICD-10 Finland
Other diseases of thymus
+∞
6.4
6
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
13.4
6.1
10
9

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
25
5.73
5.77
1.3
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
40
219
3.40
4.97
5.3
4.8
estimate
0.0
0.0
—
7
45
(3035350) Ketones [Presence] in Urine by Test strip
40
223
3.31
4.75
3.7
3.4
estimate
0.0
0.0
—
7
44
(3009261) Glucose [Presence] in Urine by Test strip
40
225
3.26
4.64
3.8
3.5
estimate
0.0
0.0
—
7
43
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
33
170
3.05
4.40
5.5
4.1
ng/l
76.3
39.5
0.32
24
107
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
36
203
2.89
3.95
6.9
8.6
mmol/l
1.2
1.2
0.09
29
167
(3023368) Bacteria identified in Blood by Culture
25
117
2.93
3.86
5.1
3.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
11
30
4.25
3.83
1.5
1.4
—
—
—
0
0
(3015736) pH of Urine
32
178
2.68
3.49
3.8
3.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
12
39
3.59
3.30
1.4
3.6
e9/l
75.5
81.6
—
7
27
(3027945) Reticulocytes/100 erythrocytes in Blood
14
52
3.20
3.14
1.9
3.8
%
1.9
2.0
0.08
14
46
(3019060) Gas panel - Arterial blood
10
30
3.79
3.05
4.0
4.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
23
118
2.52
2.85
4.3
3.7
estimate
0.0
0.0
—
7
44
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
30
175
2.41
2.81
2.2
2.1
pmol/l
100.1
93.8
0.37
17
89
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
29
170
2.35
2.66
4.1
3.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
22
114
2.45
2.64
3.5
2.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
31
189
2.30
2.57
6.2
5.0
g/l
33.0
36.3
1.67
31
179
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
24
132
2.35
2.52
3.0
3.6
ng/l
1134.6
1083.1
0.05
19
103
(3004789) Transferrin [Mass/volume] in Serum or Plasma
15
67
2.64
2.41
1.7
2.6
g/l
2.5
2.4
0.53
15
60
(3041096) Erythrocytes [Presence] in Urine by Automated
23
128
2.28
2.32
3.6
3.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
26
154
2.20
2.25
5.2
5.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
33
216
2.15
2.21
6.3
4.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
19
102
2.25
2.06
4.0
3.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
31
204
2.06
2.00
3.4
2.7
ug/l
124.2
105.2
0.21
31
188
(3022096) Basophils/100 leukocytes in Blood
32
216
2.01
1.90
6.3
6.2
%
0.8
0.7
0.52
32
197
(3003458) Phosphate [Moles/volume] in Serum or Plasma
14
68
2.37
1.88
2.6
7.2
mmol/l
1.0
1.1
0.75
14
63
(3037467) Urinalysis macro (dipstick) panel - Urine
44
334
2.14
1.87
5.5
4.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
32
217
2.00
1.86
6.6
6.4
%
2.4
2.7
0.45
32
199
(1616796) Gas panel - Central venous blood
5
12
4.43
1.86
1.4
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
24
147
2.04
1.85
4.3
2.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
32
221
1.94
1.73
7.3
6.7
%
8.7
8.4
0.17
32
204
(3026008) Bacteria identified in Urine by Culture
23
142
1.99
1.71
3.6
3.1
—
—
—
0
0
(3020891) Body temperature
5
14
3.79
1.65
7.6
3.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
7
26
2.90
1.63
1.6
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
26
171
1.91
1.60
10.0
6.6
inr
1.0
1.2
—
10
47
(3018418) pH of Serum or Plasma
21
129
1.96
1.57
3.3
4.6
ph
7.4
7.4
—
5
25
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
27
2.79
1.56
14.3
8.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
32
227
1.86
1.55
6.8
6.3
%
25.0
27.6
0.59
32
208
(3022313) Gas panel - Capillary blood
7
28
2.69
1.50
5.0
4.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
24
158
1.86
1.45
2.2
3.2
u/l
25.2
30.0
1.37
24
152
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
29
2.59
1.44
18.3
9.3
%
0.5
0.7
—
7
29
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
7
29
2.59
1.44
18.3
9.3
%
1.1
1.2
—
7
29
(3013707) Erythrocyte sedimentation rate by Westergren method
45
361
1.94
1.43
5.5
4.0
mm/h
16.8
11.1
1.58
39
326
(3042936) Bacteria identified in Isolate by Culture
12
63
2.13
1.34
1.9
1.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
25
2.55
1.27
7.8
5.6
mmol/l
25.7
24.4
—
6
25
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
21
138
1.80
1.25
3.5
2.5
u/l
51.2
56.9
0.42
21
129
(3007853) Bacteria identified in Skin by Aerobe culture
11
58
2.09
1.21
1.3
1.6
—
—
—
0
0
(3013512) EKG study
20
131
1.78
1.20
4.8
4.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
14
82
1.92
1.17
1.6
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
30
2.50
1.17
2.3
2.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
10
52
2.10
1.14
1.2
1.8
nmol/l
373.9
406.8
—
10
46
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
21
2.50
1.11
1.8
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
46
386
1.78
1.09
28.9
17.0
%
13.9
13.9
0.08
46
380
(3018095) Leukocytes [#/volume] in Urine
24
170
1.68
1.08
4.7
3.6
e6/l
93.2
49.1
0.44
17
113
(3022145) Colonoscopy Study observation
7
36
2.06
1.00
1.0
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
22
155
1.66
1.00
4.0
2.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
51
451
1.80
0.88
19.6
13.2
ml/min/173m2
82.6
83.3
0.08
44
359
(3021589) Normoblasts [#/volume] in Blood
25
188
1.56
0.86
11.4
9.3
e9/l
0.0
0.0
0.48
20
151
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
58
1.87
0.85
3.1
1.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
11
67
1.78
0.81
3.1
2.7
e6/l
9.8
4.0
—
5
32
(4010399)
6
33
1.91
0.81
1.2
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
54
1.78
0.79
1.8
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
9
54
1.78
0.79
1.7
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
13
85
1.67
0.76
2.4
1.8
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
5
25
2.09
0.74
5.2
4.9
mmol/l
23.6
24.6
—
5
25
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
43
1.71
0.69
1.1
1.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11
71
1.67
0.67
2.1
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
14
97
1.58
0.66
3.4
4.5
ug/l
1.0
2.0
2.08
14
92
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
50
1.69
0.64
3.4
1.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
5
30
1.72
0.63
1.4
2.0
ug/l
3.1
6.5
—
5
25
(3017143) Hepatitis C virus Ab [Presence] in Serum
8
52
1.62
0.62
1.9
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
18
135
1.47
0.60
3.7
3.9
mg/mmol
3.3
8.1
0.73
11
93
(3000991) Gas panel - Venous blood
6
35
1.79
0.60
17.3
10.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
17
129
1.44
0.53
2.5
3.3
mg/l
44.4
512.9
0.50
11
88
(3019832) Treponema pallidum Ab [Presence] in Serum
7
45
1.63
0.51
1.9
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
48
1.52
0.49
4.1
3.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
16
202
0.72
0.47
1.6
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
10
70
1.51
0.45
1.3
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
54
507
1.57
0.44
23.3
11.7
—
—
—
0
0
(3044889) 12 lead EKG panel
36
318
1.32
0.43
5.2
3.6
—
—
—
0
0
(4034850)
0
15
0.00
0.42
0.0
11.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
5
36
1.42
0.39
1.0
1.2
u/ml
14.0
166.8
—
5
28
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
10
73
1.44
0.37
3.5
2.6
e6/l
0.4
1.0
—
5
38
(4035726)
6
42
1.47
0.37
1.2
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
38
343
1.29
0.36
3.2
3.0
—
—
—
0
0
(3000492) Spirometry study
6
44
1.40
0.35
1.2
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
15
120
1.33
0.34
2.2
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
13
102
1.35
0.33
3.4
2.4
e6/l
8.3
4.9
0.36
13
91
(40760892) CBC W Ordered Manual Differential panel - Blood
13
103
1.33
0.31
9.8
5.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
11
85
1.36
0.30
1.3
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
51
482
1.35
0.30
25.0
13.4
mg/l
29.6
19.7
1.06
46
370
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
12
96
1.31
0.27
1.4
1.2
u/ml
2.1
0.6
—
6
21
(3026493) Urate [Moles/volume] in Serum or Plasma
14
115
1.28
0.26
2.0
3.6
umol/l
295.8
2691.3
—
9
94
(40761536) Microorganisms panel - Urine sediment
5
38
1.34
0.24
7.2
3.8
—
—
—
0
0
(3012544) pH of Venous blood
5
40
1.27
0.23
2.6
4.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
10
0.00
0.21
0.0
4.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
10
0.00
0.21
0.0
2.0
—
7.9
—
0
10
(3052851) Hemolysis interference index of Serum or Plasma
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
43
453
0.83
0.20
28.8
14.4
%
39.3
40.1
0.31
30
349
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
52
1.17
0.20
6.0
6.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
59
1.21
0.19
1.3
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
15
172
0.83
0.18
2.7
2.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
53
512
1.27
0.15
15.6
10.0
u/l
23.2
25.4
0.77
53
499
(3020564) Creatinine [Moles/volume] in Serum or Plasma
53
511
1.28
0.15
25.6
15.1
umol/l
74.8
75.8
0.12
53
511
(3019225) pH of Specimen
5
44
1.15
0.10
3.6
5.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
13
117
1.14
0.09
8.5
8.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
7
64
1.11
0.08
1.6
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
14
130
1.10
0.05
4.5
2.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
46
469
0.92
0.04
3.6
3.9
mmol/l
1.4
1.3
0.36
41
432
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
11
111
0.99
0.00
1.4
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
49
485
1.05
0.00
4.4
4.8
mmol/l
2.7
2.8
0.21
44
444
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(4281824)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
13.6
—
0
6
(3019230) Fractional oxyhemoglobin in Venous blood
0
6
0.00
0.00
0.0
4.0
—
62.2
—
0
6
(4027681)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
54
540
1.00
0.00
36.2
19.8
g/l
129.1
134.9
1.63
54
533
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
54
540
1.00
0.00
36.0
19.7
e12/l
4.3
4.5
1.23
54
526
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
2.1
—
4.0
—
0
7
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
7
0.00
0.00
0.0
1.0
—
33.3
—
0
7
(3005570) Glucose [Moles/volume] in Urine
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3024731) MCV [Entitic volume]
54
540
1.00
0.00
35.9
19.6
fl
91.1
91.1
0.03
54
534
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
5
55
0.90
0.00
1.2
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
0.8
—
0
5
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(4094501)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
54
539
1.02
0.00
35.9
19.6
pg
30.3
30.3
0.02
54
533
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
231.6
—
0
7
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
87.8
—
0
5
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
5
0.00
0.00
0.0
3.4
—
11.5
—
0
5
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
2.1
—
108.3
—
0
7
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
10.4
—
1208.0
—
0
5
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1235.0
—
0
5
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(4146454)
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
12.4
—
1861.4
—
0
5
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
4.4
—
213.1
—
0
5
(3010813) Leukocytes [#/volume] in Blood
54
540
1.00
0.00
36.0
19.9
e9/l
6.9
6.5
0.94
54
526
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
54
539
1.02
0.00
35.9
19.8
e9/l
255.1
254.5
0.02
54
529
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_THYMUSDISNAS and mortality.

Females

Parameter HR [95% CI] p-value
E4_THYMUSDISNAS 2.222 [1.27, 3.88] 0.005
Birth year 0.99 [0.98, 1.0] 0.02

During the follow-up period (1.1.1998 — 31.12.2019), 52 out of 136 females with E4_THYMUSDISNAS died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have E4_THYMUSDISNAS.

N-year risk Females Males
1 0.203% No data
5 1.219% No data
10 2.736% No data
15 5.372% No data
20 9.043% No data

Relationships between endpoints

↥

Index endpoint: E4_THYMUSDISNAS – Disease of thymus, other/unspecified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data